Total 10 Posts
The ‘jab market’ of private COVID vaccines is a good thing for public health – but not for health inequality5 min read
Privately selling COVID vaccines could boost immunity but raises worries about health inequalities. Affordability issues may limit access for lower-income individuals, worsening disparities in vaccine distribution.
The ongoing COVID-19 wave has the potential to significantly grow, with the ONS estimating a 4.3% virus prevalence in England. One expert warns that the JN.1 wave might surpass the March 2022 surge.
A new book exposes the tensions between the Treasury and health officials over the COVID-19 vaccine programme, and alleges that Steve Barclay delayed the approval of the programme due to value-for-money concerns, angering the vaccine taskforce.
A vaccine produced by Sanofi is being given as part of the 2023 spring booster campaign. An immunology expert explains how it works. I n the UK a spring booster campaign has recently begun, offering an additional vaccine to people at highest risk from COVID. Between April and June 2023
Going forward, the majority of individuals residing in the United Kingdom will only be able to achieve immunity to the virus causing COVID-19 by contracting the virus itself.